Creso Pharma (CPH)
Creso Pharma Ltd. is a medicinal cannabis manufacturer. It develops, registers, and commercializes pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments. The company was founded by Adam Blumenthal, Miri Halperin Wernli, and Boaz Wachtel on November 20, 2015 and is headquartered in West Perth, Australia.
|Market Price at 20-11-2017||$0.99|
|Price to Earnings Ratio||-1.76|
|Market Capitalisation||$47.34 (million)|
|Return on Equity (ROE)||-130.86%|